Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sonogram, Kinesiograph TMD Devices Should Be Class I With 510(k) -Panel

This article was originally published in The Gray Sheet

Executive Summary

Sonogram and kinesiograph temporomandibular joint (TMJ) devices should be classified as Class I, but are of sufficient concern to warrant submission of a 510(k), FDA's Dental Products Panel unanimously recommended (7-0) at an Aug. 5 meeting.

You may also be interested in...



TMJ Diagnostic Devices Require 510(k) Clearance, Clinical Data – FDA Rule

FDA's 11proposed rule on jaw-tracking and dental sonography devices interpreting temporomandibular joint positions or sounds will pave the way for firms to market the products for diagnosing TMJ disorder and associated orofacial pain

IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf

Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel